<code id='8E2FA5B1D6'></code><style id='8E2FA5B1D6'></style>
    • <acronym id='8E2FA5B1D6'></acronym>
      <center id='8E2FA5B1D6'><center id='8E2FA5B1D6'><tfoot id='8E2FA5B1D6'></tfoot></center><abbr id='8E2FA5B1D6'><dir id='8E2FA5B1D6'><tfoot id='8E2FA5B1D6'></tfoot><noframes id='8E2FA5B1D6'>

    • <optgroup id='8E2FA5B1D6'><strike id='8E2FA5B1D6'><sup id='8E2FA5B1D6'></sup></strike><code id='8E2FA5B1D6'></code></optgroup>
        1. <b id='8E2FA5B1D6'><label id='8E2FA5B1D6'><select id='8E2FA5B1D6'><dt id='8E2FA5B1D6'><span id='8E2FA5B1D6'></span></dt></select></label></b><u id='8E2FA5B1D6'></u>
          <i id='8E2FA5B1D6'><strike id='8E2FA5B1D6'><tt id='8E2FA5B1D6'><pre id='8E2FA5B1D6'></pre></tt></strike></i>

          Home / entertainment / leisure time

          leisure time


          leisure time

          author:hotspot    Page View:199
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In